Anti-CD142 antibody(DMC463), IgG1 Chimeric mAb
產品名稱: Anti-CD142 antibody(DMC463), IgG1 Chimeric mAb
英文名稱: Anti-CD142 antibody(DMC463), IgG1 Chimeric mAb
產品編號: DMC100463
產品價格: null
產品產地: China
品牌商標: DIMA Biotech
更新時間: null
使用范圍:
締碼生物科技(武漢)有限公司
- 聯系人 :
- 地址 : 武漢市洪山區東湖高新區高新大道666號光谷生物城B7
- 郵編 : 430070
- 所在區域 : 湖北
- 電話 : 151****5168 點擊查看
- 傳真 : 點擊查看
- 郵箱 : cygao@dimabio.com
This gene encodes coagulation factor III which is a cell surface glycoprotein. This factor enables cells to initiate the blood coagulation cascades, and it functions as the high-affinity receptor for the coagulation factor VII. The resulting complex provides a catalytic event that is responsible for initiation of the coagulation protease cascades by specific limited proteolysis. Unlike the other cofactors of these protease cascades, which circulate as nonfunctional precursors, this factor is a potent initiator that is fully functional when expressed on cell surfaces, for example, on monocytes. There are 3 distinct domains of this factor: extracellular, transmembrane, and cytoplasmic. Platelets and monocytes have been shown to express this coagulation factor under procoagulatory and proinflammatory stimuli, and a major role in HIV-associated coagulopathy has been described. Platelet-dependent monocyte expression of coagulation factor III has been described to be associated with Coronavirus Disease 2019 (COVID-19) severity and mortality. This protein is the only one in the coagulation pathway for which a congenital deficiency has not been described. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Aug 2020]
